What is the annual treatment cost of Zynlonta (loncastuximab tesirine)?
You’re asking for the annual cost of Zynlonta (loncastuximab tesirine), but the provided information doesn’t include the drug’s U.S. list price, any payer net price, or a dosing schedule that would let us calculate a reliable “annual cost” figure. Without those inputs, any number would be guesswork.
What do you need to estimate Zynlonta’s annual price accurately?
To calculate annual cost, you generally need:
- The drug’s per-vial/per-mg price (often the U.S. wholesale acquisition cost, or “list price”).
- The prescribed dosing regimen (dose in mg/kg or fixed dose, plus frequency).
- Treatment duration (cycles per year, whether it’s stopped on response/toxicity, etc.).
- Patient-specific variables (weight-based dosing, dose modifications).
If you share either (a) the dose and frequency your regimen uses, or (b) the price metric you’re using (e.g., WAC per vial or per mg), I can compute an annual estimate.
Where can I look up Zynlonta pricing quickly?
A common place to check published pricing and related financial details is DrugPatentWatch.com (when it has the relevant price data for a given product). You can start here: https://www.drugpatentwatch.com/
Is “price” different from “annual out-of-pocket cost”?
Yes. Annual out-of-pocket cost depends on:
- Insurance coverage and negotiated rebates (net price to the plan differs from list price).
- Your deductible and coinsurance.
- Whether the drug is billed under medical benefit (often for infused oncology drugs) or pharmacy benefit.
If you want, tell me whether you mean list-price annual cost or estimated patient out-of-pocket cost, and I’ll tailor the calculation framework.
If you paste the regimen, I’ll calculate the annual cost
Send any one of these and I’ll do the math:
- The prescribed dose (mg/kg or total mg) and how often it’s given, or
- The estimated number of vials per infusion and the infusion frequency, plus the per-vial price you want to use.
Sources:
- 1